Physician profile
Valery S Effoe
NPI 1962865436
$7,092.62
in general payments reported to CMS, 2019-2025
26 companies · $1,480 in 2025
The $1,480 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2021: $280 · 2022: $2,036 · 2023: $1,541 · 2024: $1,561 · 2025: $1,480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,546 · Travel and Lodging: $1,885 · Education: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,545.60 |
| Travel and Lodging | $1,884.97 |
| Education | $150.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,952.89 | 2021-2024 | Turbohawk, Symplicity G3 |
| Boston Scientific Corporation | $1,488.81 | 2019-2025 | General - Vascular Intervention, Accolade Sr, Opticross |
| Penumbra, INC. | $1,053.67 | 2024 | Ruby Coil |
| Shockwave Medical, INC | $268.57 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $172.44 | 2022 | |
| W. L. Gore & Associates, INC. | $169.08 | 2022 | |
| Chiesi USA, INC. | $119.38 | 2023-2025 | Kengreal, Cleviprex |
| Veryan Medical Incorporated | $111.52 | 2023 | Biomimics 3d Vascular Stent System |
| Astrazeneca Pharmaceuticals LP | $110.16 | 2024-2025 | Lokelma, Farxiga |
| Scpharmaceuticals INC. | $82.45 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $72.34 | 2023-2024 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $71.30 | 2024-2025 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $66.99 | 2023 | Opsumit, Uptravi |
| Pfizer INC. | $53.18 | 2025 | |
| Stryker Corporation | $48.60 | 2025 | Flowtriever, Artix Mt |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $33.60 | 2024-2025 | |
| Cook Medical LLC | $31.56 | 2024 | Zilver Ptx |
| Merck Sharp & Dohme LLC | $29.40 | 2023 | Verquvo |
| Inari Medical, INC. | $24.80 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cvrx, INC. | $22.42 | 2025 | Barostim Neo System |
| Solventum Corporation | $21.88 | 2025 | Prevena, V.A.C.Ulta |
| Abbott Laboratories | $21.32 | 2022 | |
| Novo Nordisk INC | $19.15 | 2024 | Rybelsus, Ozempic |
| Sanofi-Aventis U.S. LLC | $18.15 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.50 | 2025 | |
| Amgen INC. | $13.46 | 2025 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Valery Effoe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.